Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 3.09B P/E - EPS this Y 30.90% Ern Qtrly Grth -
Income -131.59M Forward P/E -44.02 EPS next Y 31.50% 50D Avg Chg -4.00%
Sales 537.09M PEG - EPS past 5Y - 200D Avg Chg -9.00%
Dividend N/A Price/Book 13.90 EPS next 5Y - 52W High Chg -39.00%
Recommedations 1.50 Quick Ratio 6.61 Shares Outstanding 31.24M 52W Low Chg 18.00%
Insider Own 0.82% ROA -9.36% Shares Float 30.95M Beta 1.22
Inst Own 116.04% ROE -81.46% Shares Shorted/Prior 2.69M/2.57M Price 101.25
Gross Margin 67.19% Profit Margin -24.50% Avg. Volume 391,438 Target Price 122.00
Oper. Margin -15.52% Earnings Date Oct 31 Volume 333,044 Change -2.50%
About iRhythm Technologies, Inc.

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

iRhythm Technologies, Inc. News
11/20/24 iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference
11/18/24 Inside a $400 billion bet on the brain-computer interface revolution
11/18/24 iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring
11/05/24 iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference
11/01/24 Here’s Why iRhythm Technologies (IRTC) Slid in Q3
11/01/24 iRhythm Technologies, Inc. (NASDAQ:IRTC) Just Reported, And Analysts Assigned A US$101 Price Target
11/01/24 FDA clears iRhythm’s second 510(k) in response to warning letter
10/31/24 iRhythm Technologies Inc (IRTC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...
10/30/24 IRhythm Technologies (IRTC) Reports Q3 Loss, Tops Revenue Estimates
10/30/24 iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device
10/30/24 iRhythm Technologies Announces Third Quarter 2024 Financial Results
10/28/24 Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy
10/23/24 iRhythm Technologies (IRTC) Soars 21.7%: Is Further Upside Left in the Stock?
10/23/24 iRhythm’s Zio AT design changes win FDA clearance
10/22/24 With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst Says
10/22/24 iRhythm's Stock Skyrockets 17% After Game-Changing FDA Approval -- Is This Just the Beginning?
10/22/24 iRhythm Technologies Stock Rises Post FDA Clearance for Zio AT
10/22/24 iRhythm shares soar after FDA clears Zio AT device updates
10/22/24 iRhythm secures 510(k) clearance for Zio device updates after FDA warning
03:05 PM iRhythm Technologies Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio® AT Device
IRTC Chatroom

User Image DallasChristensen_ Posted - 1 day ago

$IRTC $SDOT LFG, expected this to move higher. Also, your thoughts on MYNZ? Who's behind the 30M share offering deal? 👀 And how could the Thermo Fisher (TMO) partnership ($210B market cap) reflect this stock movement and PR buzz everywhere on socials?

User Image Nullify Posted - 1 week ago

$IRTC nice

User Image VincyStock Posted - 1 week ago

$IRTC You Got Me Still.

User Image MaverikIT Posted - 1 week ago

@IsabellaDC @net0trader $SE $IRTC $CAMT $DAVA been turning

User Image Nullify Posted - 2 weeks ago

$IRTC another nice day

User Image QuiverQuant Posted - 2 weeks ago

Insider Purchase: Director at Irhythm Technologies ($IRTC) Buys 6,664 Shares Read the full story here: https://www.quiverquant.com/news/Insider+Purchase%3A+Director+at+Irhythm+Technologies+%28IRTC%29+Buys+6%2C664+Shares

User Image swingingtech Posted - 2 weeks ago

$CMCO $IRTC https://wallstreetwaves.com/insider-trading-insights-key-purchases-in-cmco-and-irtc-on-november-5th/

User Image insiderbuyingselling Posted - 2 weeks ago

$IRTC new insider buying: 6664 shares. http://insiderbuyingselling.com/?t=IRTC

User Image AlexH_Finesse Posted - 2 weeks ago

🚨 MYNZ HUGE PR drop incoming before the Nov 13 meeting 🔥 Someone is pushing these dates of upcoming NEWS 3 biggest stock alert channels announced, might consider to add now, who knows. $IRTC $SDOT $RCEL $LINK

User Image healthcareguru Posted - 2 weeks ago

$IRTC no reason for this to be up after highly disappointing MCT delay (again)…tactical short back to $65…still facing a ton of tax loss selling pressure into YE too. 👎 $XLV $IWM $IHI

User Image WarrenPuffett Posted - 10/31/24

$IRTC $MDGL $MSM $NVDA $ST $MDGL up 20% on earnings. That played out well so far. Rolled up $ST to a larger position yesterday.

User Image DonCorleone77 Posted - 10/30/24

$IRTC iRhythm gets FDA 510(k) clearance for design modifications to Zio AT device iRhythm Technologies announced that the U.S. FDA has granted clearance for its 510(k) submission related to design modifications and labeling updates for the Zio AT device. Zio AT remains commercially available on the market to ship to customers in the United States, and product enhancements subject to this 510(k) clearance will be available in 2025.

User Image DonCorleone77 Posted - 10/30/24

$IRTC iRhythm sees FY24 revenue $$582.5M- $587.5M, consensus $585.33M iRhythm projects revenue for the full year 2024 to grow approximately 18% to 19% compared to prior year results, ranging from approximately $582.5 million to $587.5 million. Gross margin for the full year 2024 is expected to range from 68.5% to 69.0%. iRhythm now expects adjusted EBITDA margin for the full year 2024 to range from approximately negative 2% to negative 1.5% of full year revenues. Adjusted EBITDA guidance includes license consideration payable to BioIntelliSense that is recognized on iRhythm's consolidated statements of operations as acquired IPR&D expenses, including a charge of approximately $32 million of expense incurred during the third quarter of 2024. In alignment with SEC guidance around non-GAAP financial measures relating to acquired IPR&D expense, iRhythm will not exclude expenses related to acquired IPR&D from its non-GAAP results, which include adjusted EBITDA.

User Image DonCorleone77 Posted - 10/30/24

$IRTC iRhythm reports Q3 EPS($1.26) , consensus (57c) Reports Q3 revenue $$147.5M , consensus $146.73M."The third quarter of 2024 was an exceptional quarter of execution as our teams drove significant demand in our core business, made substantial progress in expanding our Zio services into global markets, and established an important licensing agreement with an external partner to drive future platform capabilities for long term growth," said Quentin Blackford, president and chief executive officer of iRhythm. "Third quarter revenue growth of over 18% year-over-year was driven by record volume demand from existing accounts, and our field teams were also able to open a record number of new accounts during the quarter while continuing our expansion into primary care channels. We were also very pleased to be able to celebrate one million patients having been registered for Zio monitor - our newest generation, long-term continuous monitoring system - in October and have officially launched our first commercial account using Aura - Epic's specialty diagnostics and devices suite.""We also made tangible progress towards long-term initiatives to drive future growth. For the first time ever, we have achieved more than 10,000 billable registrations in a single quarter in the UK, and we are excited that we have begun receiving physician orders following commercial launch in four additional European countries. Furthermore, we have recently received a FDA 510(k) clearance for updates to our Zio AT device associated with our FDA remediation efforts, an ongoing and critical priority for our teams to demonstrate our commitment to quality, compliance and performance. With strong execution across multiple growth levers and with additional catalysts on the horizon, we could not be more excited about the future of iRhythm."

User Image 1986iamwallstreet Posted - 10/30/24

$IRTC flushing

User Image 1986iamwallstreet Posted - 10/30/24

$IRTC below 70 in play ……

User Image 1986iamwallstreet Posted - 10/30/24

$IRTC iRhythm Technologies Q3 2024 Adj EPS $(1.26) Misses $(0.57) Estimate, Sales $147.50M Beat $146.73M Estimate Crazy EPS miss

User Image RockyTSTH Posted - 10/30/24

$IRTC iRhythm Technologies Q3 2024 Adj EPS $(1.26) Misses $(0.57) Estimate, Sales $147.50M Beat $146.73M Estimate

User Image healthcareguru Posted - 10/30/24

$IRTC Quentin already said in Sept at a conf don’t expect a big beat…question is if they’re lowing guide again? Still not out of the woods with FDA issues.

User Image phatsuit Posted - 10/29/24

$IRTC Earnings morning or afternoon?

User Image Laynester Posted - 10/28/24

$WNS $IRTC $IEP $TDC TOP 4 - LOW RSI solid turnaround future perfect KINGS!!! All up today. Get IN the TREND for long term RSI gains - NOW.

User Image Estimize Posted - 10/28/24

Estimize revenue expectations are 0.48% higher than that of Wall Street for $IRTC Q3 [Reporting 10/30 AMC] http://www.estimize.com/intro/ir

User Image Laynester Posted - 10/25/24

$IRTC Great W/S bottom fishing charter here. No tipping the captain or the mates either. 3yr chart Bull Case: IRTC 1. Price is increasing. 2. RSI (very low) is increasing. 3. M/Flow is increasing. 4. Elliott Wave moving red to green (bull cycle indicator). 5. Aroon moving blue on top over red on bottom (bull cycle indicator). Cast your poles we're on top of Lunker reef! Set your (reel) drag to 8% trlr stop to avoid breaking your rod on a big Stinker Sinker. 3yr IRTC graph attached below the indicators highlighted:

User Image WarrenPuffett Posted - 10/24/24

Current POS $ST - heavy $MSM - light $MDGL - starter Eyeing $NVDA $IRTC had UOA a week or so ago and they got news. Someone always knows!

User Image Nullify Posted - 10/22/24

$IRTC nice day

User Image TheBigGotBigger Posted - 10/22/24

$IRTC Push you son of a bitch

User Image tradingtwenty Posted - 10/22/24

$IRTC has trended 25 times in the past 24 hours (based on 5 minute intervals). Latest press release on Oct 21, 2024 04:05 PM: iRhythm Technologies Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio® AT Device Link: https://tradingtwenty.com/news/666442/irhythm-technologies-receives-fda-510k-clearance-for-design-updates-previously-made-to-its-zio-at-device

User Image LewisDaKat Posted - 10/22/24

$IRTC News Article Outperform Recommendation Issued On IRTC By Oppenheimer https://marketwirenews.com/news-releases/outperform-recommendation-issued-on-irtc-by-oppenhei-7368520674310212.html $IRTC

User Image Stocksrunner Posted - 10/22/24

@healthcareguru FDA clearance is a big deal for $IRTC. Even small updates can spark excitement and drive momentum. Let’s see how it plays out

User Image healthcareguru Posted - 10/22/24

$IRTC fade it…shouldn’t be up 20% for just doing what guide was…this is only short covering; it will reverse.

Analyst Ratings
Canaccord Genuity Buy Sep 25, 24
Citigroup Buy Aug 22, 24
JP Morgan Overweight Aug 2, 24
Oppenheimer Outperform Aug 2, 24
Baird Outperform Aug 2, 24
Truist Securities Buy Aug 2, 24
Needham Buy Aug 2, 24
Truist Securities Buy Jul 16, 24
Morgan Stanley Overweight Jul 15, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Murphy Patrick Michael CBO and CLO CBO and CLO Dec 05 Sell 88.82 1,686 149,751 30,751 12/06/23
Blackford Quentin S. President and CEO President and CEO Jun 06 Buy 102.27 9,755 997,644 128,510 12/06/23
Day Mark J. Chief Technology Off.. Chief Technology Officer Aug 03 Option 36.22 486 17,603 55,522 08/04/23
Patterson Chad Chief Commercial Off.. Chief Commercial Officer Aug 02 Sell 100.49 1,896 190,529 30,200 08/02/23
Wilson Daniel G. EVP, Corp Dev Inv Re.. EVP, Corp Dev Inv Rel Jul 03 Sell 103.48 1,490 154,185 33,847 07/03/23
Turakhia Minang EVP, CMO & CSO EVP, CMO & CSO Jul 03 Sell 103.48 988 102,238 19,719 07/03/23
Wilson Daniel G. EVP, Corp Dev Inv Re.. EVP, Corp Dev Inv Rel Mar 29 Sell 125 4,000 500,000 35,337 03/30/23
Murphy Patrick Michael CLO & EVP RA/QA Mrkt.. CLO & EVP RA/QA MrktAcs & Gov Mar 03 Sell 117.23 571 66,938 32,437 03/07/23
Day Mark J. Chief Technology Off.. Chief Technology Officer Mar 03 Sell 117.23 2,116 248,059 54,815 03/07/23
Wilson Daniel G. EVP, Strategy Corp D.. EVP, Strategy Corp Dev Inv Rel Mar 03 Sell 117.23 1,422 166,701 39,337 03/07/23
Devine Douglas Chief Operating Offi.. Chief Operating Officer Mar 03 Sell 117.23 1,473 172,680 29,566 03/07/23
Wilson Daniel G. EVP, Strategy Corp D.. EVP, Strategy Corp Dev Inv Rel Feb 27 Sell 118.63 1,726 204,755 40,759 03/01/23
Devine Douglas Chief Operating Offi.. Chief Operating Officer Feb 27 Sell 118.52 3,518 416,953 31,039 03/01/23
Day Mark J. Chief Technology Off.. Chief Technology Officer Feb 27 Sell 118.56 1,913 226,805 56,931 03/01/23
Murphy Patrick Michael CLO & EVP RA/QA Mrkt.. CLO & EVP RA/QA MrktAcs & Gov Dec 02 Sell 106.78 1,704 181,953 23,726 12/06/22
Blackford Quentin S. President and CEO President and CEO Nov 02 Sell 120.34 12,699 1,528,198 89,280 11/04/22
Devine Douglas Chief Operating Offi.. Chief Operating Officer Sep 29 Sell 125 2,000 250,000 27,702 09/30/22
Wilson Daniel G. EVP, Strategy Corp D.. EVP, Strategy Corp Dev Inv Rel Sep 26 Sell 123.02 3,000 369,060 34,562 09/28/22
Bairey Merz Cathleen Noel Director Director Sep 12 Sell 159.77 90 14,379 4,887 09/14/22
Devine Douglas Chief Operating Offi.. Chief Operating Officer & CFO Jul 07 Sell 114.22 10,109 1,154,650 29,702 07/11/22
Wilson Daniel G. EVP, Strategy Corp D.. EVP, Strategy Corp Dev Inv Rel Jul 05 Sell 108.36 1,428 154,738 37,562 07/07/22
Devine Douglas Chief Operating Offi.. Chief Operating Officer & CFO Jul 05 Sell 107.73 1,239 133,477 39,811 07/07/22
Bairey Merz Cathleen Noel Director Director Jun 14 Sell 111.7608 500 55,880 4,977 06/16/22
Devine Douglas Chief Operating Offi.. Chief Operating Officer & CFO Jul 08 Sell 59.5584 1,212 72,185 30,247 03/22/22
Wilson Daniel G. EVP, Strategy Corp D.. EVP, Strategy Corp Dev Inv Rel Jul 08 Sell 59.5586 2,039 121,440 34,044 03/22/22
Devine Douglas Chief Operating Offi.. Chief Operating Officer & CFO Mar 04 Sell 132.6733 576 76,420 41,955 03/08/22
Vort David A Chief Commercial Off.. Chief Commercial Officer Mar 04 Sell 132.6721 3,161 419,377 27,952 03/08/22
Wilson Daniel G. EVP, Strategy Corp D.. EVP, Strategy Corp Dev Inv Rel Mar 04 Sell 132.6707 1,331 176,585 41,029 03/08/22
King Kevin M Director Director Mar 04 Sell 132.6721 6,815 904,160 250,422 03/08/22
Day Mark J. EVP, Research & Deve.. EVP, Research & Development Mar 04 Sell 132.6723 2,518 334,069 46,705 03/08/22
Vort David A Chief Commercial Off.. Chief Commercial Officer Feb 15 Sell 119.95 2,845 341,258 31,113 02/17/22
Devine Douglas Chief Operating Offi.. Chief Operating Officer & CFO Feb 15 Sell 119.95 4,603 552,130 42,531 02/17/22
Wilson Daniel G. EVP, Strategy Corp D.. EVP, Strategy Corp Dev Inv Rel Feb 15 Sell 119.96 2,652 318,134 42,360 02/17/22
Day Mark J. EVP, Research & Deve.. EVP, Research & Development Feb 15 Sell 119.99 4,062 487,399 49,223 02/17/22